Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current therapy for malignant mesothelioma.

Literature DB >> 12044240

Current therapy for malignant mesothelioma.

Abstract

This review briefly summarizes the results of previous systemic (chemotherapy) and local (surgery and radiotherapy) treatment attempted to date for malignant mesothelioma. The prospects for newer modalities, ie molecular and biologic therapies, are also highlighted, including results of both preclinical and early clinical research.

Entities: Chemical

Mesh：

Substances：

Year: 2002 PMID： 12044240 DOI： 10.1007/s11912-002-0006-2

Source DB: PubMed Journal: Curr Oncol Rep ISSN： 1523-3790 Impact factor: 5.945

73 in total

1. Pelvic and lumbar metastasis detected by bone scintigraphy in malignant pleural mesothelioma.

Authors: G Ruíz Hernández; T García García; P Azagra Ros; J I Maruenda Paulino; C Ferrer Albiach; F J Castillo Pallarés; L Llorens Bañón; C Romero de Avila y Avalos
Journal: Nuklearmedizin Date: 1999 Impact factor: 1.379

2. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

Authors: V W Rusch; S Piantadosi; E C Holmes
Journal: J Thorac Cardiovasc Surg Date: 1991-07 Impact factor: 5.209

3. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.

Authors: X X Cao; I Mohuiddin; F Ece; D J McConkey; W R Smythe
Journal: Am J Respir Cell Mol Biol Date: 2001-11 Impact factor: 6.914

4. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.

Authors: I Waheed; Z S Guo; G A Chen; T S Weiser; D M Nguyen; D S Schrump
Journal: Cancer Res Date: 1999-12-15 Impact factor: 12.701

5. DNA copy number changes in familial malignant mesothelioma.

Authors: V Ascoli; Y Aalto; C Carnovale-Scalzo; F Nardi; D Falzetti; C Mecucci; S Knuutila
Journal: Cancer Genet Cytogenet Date: 2001-05

6. Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium.

Authors: K Segers; M Ramael; S K Singh; J Weyler; J Van Meerbeeck; P Vermeire; E Van Marck
Journal: Virchows Arch Date: 1994 Impact factor: 4.064

7. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors: V W Rusch; K Rosenzweig; E Venkatraman; L Leon; A Raben; L Harrison; M S Bains; R J Downey; R J Ginsberg
Journal: J Thorac Cardiovasc Surg Date: 2001-10 Impact factor: 5.209

Current therapy for malignant mesothelioma.

1. Pelvic and lumbar metastasis detected by bone scintigraphy in malignant pleural mesothelioma.

2. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

3. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.

4. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.

5. DNA copy number changes in familial malignant mesothelioma.

6. Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium.

7. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Review 8. The role of gemcitabine in the treatment of malignant mesothelioma.

9. Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience.

10. SV40 induces mesotheliomas in hamsters.

1. Factors influencing long-term survival in mesothelioma patients--results of the German mesothelioma register.

2. Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma.